Neuronetics/$STIM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neuronetics
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
Ticker
$STIM
Sector
Primary listing
Employees
658
Headquarters
Website
Neuronetics Metrics
BasicAdvanced
$141m
-
-$0.59
0.87
-
Price and volume
Market cap
$141m
Beta
0.87
52-week high
$4.85
52-week low
$0.80
Average daily volume
2.1m
Financial strength
Current ratio
2.017
Quick ratio
1.469
Long term debt to equity
322.95
Total debt to equity
344.143
Interest coverage (TTM)
-3.69%
Profitability
EBITDA (TTM)
-27.631
Gross margin (TTM)
48.75%
Net profit margin (TTM)
-26.15%
Operating margin (TTM)
-20.81%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
-13.73%
Return on equity (TTM)
-134.86%
Valuation
Price to revenue (TTM)
0.893
Price to book
6.23
Price to tangible book (TTM)
-6.9
Price to free cash flow (TTM)
-6.291
Free cash flow yield (TTM)
-15.89%
Free cash flow per share (TTM)
-0.321
Growth
Revenue change (TTM)
99.17%
Earnings per share change (TTM)
-57.07%
3-year revenue growth (CAGR)
31.76%
3-year earnings per share growth (CAGR)
-24.64%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neuronetics stock?
Neuronetics (STIM) has a market cap of $141M as of May 03, 2026.
What is the P/E ratio for Neuronetics stock?
The price to earnings (P/E) ratio for Neuronetics (STIM) stock is 0 as of May 03, 2026.
Does Neuronetics stock pay dividends?
No, Neuronetics (STIM) stock does not pay dividends to its shareholders as of May 03, 2026.
When is the next Neuronetics dividend payment date?
Neuronetics (STIM) stock does not pay dividends to its shareholders.
What is the beta indicator for Neuronetics?
Neuronetics (STIM) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.